The Role of Magnetic Resonance Imaging in the Diagnosis of Spinal Dumbell Neurofibromatosis: A Case Report from a Specialist Hospital in Port Harcourt

Chidinma Wekhe

Department of Radiology, Rivers State University Teaching Hospital, Nigeria.

Vivian Ndidi Akagbue *

Department of Radiology, Rivers State University Teaching Hospital, Nigeria.

*Author to whom correspondence should be addressed.


Abstract

Neurofibromatosis occurring in the spine also known as spinal neurofibromatosis (SNF) is a rare disease entity and they occur either unilaterally or bilaterally at the spinal roots. The low prevalence rate of the disease and scarcity of previous literatures is the main aim for this report.

Our case study is a 29-years-old lady who presented to the Radiology department for a lumbosacral spine MRI, on account of both lower limb weakness, paresthesia, unsteady gait and finally inability to walk. The symptoms have been there since she was 14 years (15 years of progressive symptoms). She also presented with multiple macules on the skin (café au lait spots). Magnetic Resonance Imaging (MRI) of the lumbosacral spine revealed bilateral spinal neurofibromas at the spinal roots of the fourth lumbar vertebra to the sacral/coccygeal vertebrae with destruction of the sacro-coccygeal bones. MRI of the brain revealed no abnormalities in the brain and optic tract. The patient fulfilled the National Institutes of Health (NIH) criteria and that of revised diagnostic criteria for Neurofibromatosis (NF1).

The patient also presented with lack of pain which could be due to impairment in sensory neurons. We describe a case of spinal neurofibromatosis diagnosed by MRI in a young lady with progressive lower limb weakness, paresthesia, sensory loss, café-au- lait spots and paraplegia.

Keywords: Spinal neurofibromatosis (SNF), magnetic resonance imaging, café-au-lait spots


How to Cite

Wekhe, C., & Akagbue, V. N. (2023). The Role of Magnetic Resonance Imaging in the Diagnosis of Spinal Dumbell Neurofibromatosis: A Case Report from a Specialist Hospital in Port Harcourt. International Journal of Medical and Pharmaceutical Case Reports, 16(3), 14–19. https://doi.org/10.9734/ijmpcr/2023/v16i3335

Downloads

Download data is not yet available.

References

Riccardi VM. Neurofibromatosis: phenotype natural history and pathogenesis. Plastic Reconst Surg. 1993;91:561.

DOI: 10. 1097/00006534-199303000-00029. CrossRef Full Text I Google Scholar

Stumpf DA, Alksne JF, Annegers JF, Brown SS, Conneally PM, Housman D. Neurofibromatosis: Conference statement. Arch Neurol. 1998;45:575-8. DOI: 10. 1001/archneur. 1998. 00520290115023. PubMed Abstract I CrossRef Full Text I Google Scholar.

Viskochil D. Alternate and related forms of the neurofibromatosis. Neurofibromin Pathog Clin Overview. 1994: 4m45-74.

Google Scholar.

Ars E, Kruyer H, Gaona A, Casquero P, Rosell J, Volpini V, et al. A clinical variant of neurofibromatosis type 1: familial spinal neurofibromatosis with a frameshift mutation in the NF1 gene. Am J Human Genet. 1998;62:834-41.

DOI: 10. 1086/301803 PubMed A bstract I CrossRef Full Text I Google Scholar

Seppala MT, Sainio MA, Haltia MJJ, Kinunnen JJ, Setala KH, Jaaskelainen JE. Multiple schwannomas: Schwannomatosis or neurofibromatosis type 2? J Neurosurg. 1998;89:36-41.DOI: 10.3171/jns. 1998. 89.1 0036. PubMed Abstract I CrossRef Full Text I Google Scholar.

Tamura R. Current understanding of neurofibromatosis type 1, 2, and schwannomatosis. Int J Mol Sci. 2021; 22:5850. DOI: 10. 3390/ijms22115850.Pubmed Abstract I Cross Ref Full Text I Google Scholar.

Smith MJ, Bowers NL, Bulman M, Golkhale C, Wallace AJ, King AT, et al. Revisiting neurofibromatosis type 2 diagnostic criteria to exclude LZTR1 – related schwannomatosis. Neurology. 2017;88: 87-92. DOI: 10.1212/WNL. 0000000000003418. PubMed Abstract I

CrossRef Full Text I Google Scholar

Kresak JL, Walsh M. Neurofibromatosis: a review of NF1, NF2 and schwannomatosis. J Pediatr Genet. 2016;05:098-104. DOI: 10.1055/s-0036-1579766 PubMed Abstract I CrossRef Full TextI I Google Scholar

Ning Z, Yang Z, Chen G, Wu W, He L, Sun Y, et al. Spinal neurofibromatosis with NF1 mutation in a classic neurofibromatosis type 1 family: a case report and literature review. Mol Genet Genomic Med. 2020;8:e1035.

DOI: 10. 1002/mgg3 1035 PubMed Abstract I CrossRef Full Text I Google Scholar

Trovo-Marqui AB, Tajara EH. Neurofibromin a general outlook. Clin Genet. 2006;70:1-13.

DOI: 10. 1111/j. 1399-0004 2006.00639. x PubMed Abstract I CrossRef Full Text I Google Scholar.

LI F, Munchhof AM, White HA, Mead LE, Krier TR, Fenoglio A, et al. Neurofibromin is a novel regulator of RAS – induced signals in primary vascular smooth muscle cells. Human Mol Genet. (2006) 15: 1921-30. DOI: 10. 1093/hmg/ddI114 PubMed Abstract I CrossRef Full Text I Google Scholar

Legius E, Messiaen L, Wolkenstein P, Pancza P, Avery RA, Berman Y, et al. Revised diagnostic criteria for neurofibromatosis tyoe 1 and Legius syndrome: an international consensus recommendation. Genet Med. 2021; 23:1506-13. DOI: 10. 1038/s41436-021-01170-5 PubMed Abstract I CrossRef Full Text I Google Scholar

Ahlawat S, Eley JO, Langmead S, Belzberg AJ, Fayad LM. Current status and recommendations for imaging in neurofibromatosis type 1, neurofibromatosis type 2 and schwannomatosis. Skeletal Radiol. 2020; 49:199-219.

DOI: 10. 1007/ s00256-019-03290-1 PubMed Abstract I CrossRef Full Text I Google Scholar

Begqvist C, Servy A, Valeyrie- Allanore L, Ferkal S, Combemale P, Wolkensteinliterature P, et al. Neurofibromatosis 1 french national guidelines based on an extensive literature review since 1966. Orphanet J Rare Dis. 2020;15: 37. DOI: 10. 1186/s13023-020-1310-3 PubMed Abstract I CrossRef Full Text I Google Scholar

Kallionpaa RA, Uusitalo E, Leppavirta J, Poyhonen M, Peltonen S, Peltonen J. Prevalence of neurofibromatosis type 1 in the Finnish population. Genet Med. 20038/gim8;20:1082-6. DOI:10. 1038/gim.2017.215 PubMed Abstract I CrossRef Full Text I Googke Scholar

Ruggieri M, Polizz’i A, Spalice A, Salpietro V, Caltabiano R, D’ Orazi V, et al. The natural history of spinal neurofibromatosis: a critical review of clinical and genetic features. Clin Genet. 2015;87: 401-10.

DOI: 10, 1111/cge. 12498PubMed Abstract I CrossRef Full Text I Google Scholar

Korf BR. Spinal neurofibromatosis and phenotypic heterogeneity in NF1. Clin Genet. 2015;87:399-400.

DOI: 10, 1111/cge 12532 PubMed Abstract I CrossRef Full Text I Google Scholar